Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Clinicians’ Use of ‘Safer’ Opioid-Prescribing Practices Spotty

Anne Harding  |  March 5, 2019

NEW YORK (Reuters Health)—Many U.S. clinicians aren’t following risk-mitigation practices for opioid prescribing, new findings show.

“In response to this national opioid crisis, consensus-based safer opioid prescribing guidelines have been published and state laws regulating opioid prescribing practices have been enacted,” Daniel P. Alford, MD, of Boston University School of Medicine, and colleagues write in Pain Medicine, online Feb. 21.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The researchers looked at whether registrants for an opioid-prescribing education program they developed were following five guideline-recommended risk-mitigation practices at baseline, establishing patient and prescriber agreements, informing patients about safe opioid storage and disposal, counseling them on respiratory depression and overdose risk, and discussing patient monitoring for opioid misuse.

Their sample included nearly 6,900 health providers (4,797 physicians, 1,395 advance practice nurses and 697 physician assistants) who participated in Safe and Competent Opioid Prescribing Education (SCOPE of Pain), a two-hour live or online case-based lecture, between 2013 and 2016.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Overall, 68% of registrants said they used at least four of the five practices for “most or all” patients, while 49% used all five for “most or all” patients. Forty-five percent said they used at least four practices with “all” patients, and 28% reported using all five practices in all patients.

Advanced practice nurses were more likely to report following all five practices with all of their patients than physician assistants or physicians. Providers in states with the highest rates of drug overdose were more likely to report using four or five of the practices in “all” and “most or all” of their patients, compared with those working in states with the lowest overdose rates.

“It’s great that folks are aware of what the right thing to do is for the most part, but just applying it more widely is what’s needed,” Dr. Alford tells Reuters Health by phone.

“We need to move beyond just imparting knowledge or knowledge acquisition and we need to better understand what the challenges are to implementing these things and training on those issues,” he adds. “So much of the emphasis on training on opiates and prescribing and chronic pain has been focused on the person who’s writing the prescription, and that’s asking too much. We need to train the entire team to work together.”

There is actually no evidence to support the effectiveness of the five practices included in the study, or for any other recommended strategies for reducing opioid misuse by educating clinicians, Dr. Alford notes.

Page: 1 2 | Single Page
Share: 

Filed under:AnalgesicsDrug Updates Tagged with:opioidOpioid abuseopioid crisisprescribing

Related Articles
    ah_designs / shutterstock.com

    The Perils of Pain Meds Revisited

    December 18, 2018

    More than 10 years ago, I wrote a commentary in The Rheumatologist, called “Perils of Pain Meds,” about the over-prescribing of opioid analgesics for common causes of chronic noncancer pain, which was a major contributor to the opioid epidemic.1 Since that time, although there has been a greater than 20% decrease in opioid prescribing, the…

    Speak Out Rheum: How Did We Go So Wrong with Opioid Prescribing?

    November 4, 2022

    I have been listening to The Fighter Pilot Podcast because my fantasy career would have been to fly a jet fighter plane (not even remotely possible, given my constitution). I learned that when an aircraft accident occurs, a mishap board is convened, not to assign blame but to try to learn what went wrong and…

    Rheumatologists Respond to Prescription Opioid Analgesic Crisis

    May 16, 2017

    The alarming statistics on prescription opioid overdoses are well known to medical professionals, thanks to the Centers for Disease Control and Prevention (CDC)’s widely cited finding that deaths from opioid analgesics have increased fourfold since 1999.1 Half of all fatal drug overdoses now involve opioids prescribed by a doctor. Meanwhile, a lack of rigorous research…

    Are Opioid Contracts Helpful or Harmful?

    October 18, 2019

    The opioid epidemic in the U.S. has destroyed thousands of lives and torn families apart. According to the Centers for Disease Control and Prevention, an average of 130 people in the U.S. die each day from an opioid overdose. From 1999 to 2017, more than 700,000 died as a result of drug overdoses. In 2017,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences